NADAC acquisition cost data for RAYOS DR 5 MG TABLET. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 75987002201 | $88.11 | 2022-05-18 | Rx |
| 75987002201 | $88.11 | 2022-05-18 | Rx |
| 75987002201 | $88.11 | 2022-05-18 | Rx |
| 75987002201 | $88.11 | 2022-05-18 | Rx |
| 75987002201 | $88.11 | 2022-05-18 | Rx |
| 75987002201 | $88.11 | 2022-05-18 | Rx |
| 75987002201 | $88.11 | 2022-05-18 | Rx |
| 75987002201 | $88.11 | 2022-05-18 | Rx |
| 75987002201 | $88.11 | 2022-05-18 | Rx |
| 75987002201 | $88.11 | 2022-05-18 | Rx |
Generic: Prednisone | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $27.3M | 5,187 | 1,437 | $87.26 |
| 2020 | $23.8M | 4,648 | 1,160 | $92.01 |
| 2021 | $21.8M | 4,563 | 1,201 | $93.69 |
| 2022 | $25.3M | 5,305 | 1,466 | $95.11 |
| 2023 | $20.3M | 4,004 | 889 | $95.36 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $4.6M | 908 | 177 |
| California | $4.0M | 770 | 162 |
| Texas | $2.1M | 510 | 105 |
| Connecticut | $1.4M | 190 | 35 |
| New Jersey | $1.0M | 236 | 37 |
| Michigan | $817.9K | 163 | 46 |
| Georgia | $539.7K | 122 | 31 |
| North Carolina | $513.5K | 86 | 24 |
| Maryland | $470.3K | 64 | 17 |
| South Carolina | $466.8K | 60 | 16 |
| Ohio | $411.7K | 72 | 18 |
| Florida | $400.8K | 82 | 41 |
| Alabama | $335.8K | 80 | 17 |
| Indiana | $330.8K | 73 | 16 |
| Massachusetts | $292.3K | 28 | N/A |
| Pennsylvania | $287.6K | 78 | 17 |
| Louisiana | $278.7K | 49 | 11 |
| Nevada | $263.7K | 55 | N/A |
| Arizona | $261.5K | 46 | 14 |
| Tennessee | $167.5K | 43 | 11 |
| Oklahoma | $166.3K | 35 | N/A |
| Kentucky | $139.7K | 44 | N/A |
| Virginia | $110.9K | 18 | N/A |
| West Virginia | $104.1K | 13 | N/A |
| Washington | $99.3K | 29 | N/A |
| Oregon | $94.2K | 21 | N/A |
| Idaho | $85.9K | 16 | N/A |
| Colorado | $85.6K | 17 | N/A |
| Illinois | $84.0K | 23 | N/A |
| Missouri | $77.1K | 12 | N/A |
| Hawaii | $15.4K | 12 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.